NEW MJ NEWS

AbbVie to Host First-Quarter 2024 Earnings Conference Call

AbbVie (NYSE: ABBV) will announce its first-quarter 2024 financial results on Friday, April 26, 2024, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time. It will be accessible through AbbVie’s Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie’s mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube.

View original content to download multimedia:https://www.prnewswire.com/news-releases/abbvie-to-host-first-quarter-2024-earnings-conference-call-302107732.html

SOURCE AbbVie


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

GrowGeneration Corp. (GRWG) Acquires Mendocino Greenhouse and Garden Supply

GrowGeneration Acquires Mendocino Greenhouse and Garden Supply, Expands Footprint in California’s Emerald…

$INSY to Present at JMP Securities Life Sciences Conference 2015

Insys Therapeutics to Present at JMP Securities Life Sciences Conference 2015  Insys…

TILT Holdings Inc. (TLLTF) Reaches Agreement with Massachusetts Cannabis Control Commission

TILT Reaches Agreement with Massachusetts Cannabis Control Commission TILT Holdings Inc. (“TILT”…

Tetra Bio-Pharma Inc. (TBPMF) Announces a Non-Brokered Private Placement

Tetra Bio-Pharma Inc. Announces a Non-Brokered Private Placement Tetra Bio-Pharma Inc. (“Tetra”…